Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hemogenyx Pharmaceuticals Plc.
(OP:
HOPHF
)
0.0031
UNCHANGED
Last Price
Updated: 12:21 PM EDT, Aug 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Hemogenyx Pharmaceuticals Plc.
< Previous
1
2
Next >
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
October 02, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 26, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
September 08, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
September 01, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference
August 27, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation
July 28, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Operations Update
June 16, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Brain Delivery
February 15, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Intranasal Delivery
February 13, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces FDA Consents to Phase I Trials of HEMO-CAR-T
February 08, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
June 27, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 24, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
March 27, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program
March 12, 2024
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) Dr Vladislav Sandler joins Proactive's Stephen Gunnion after the pre-clinical stage biopharmaceutical group raised £3.5 million, which will be...
Via
TheNewswire.com
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 million
February 28, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces the Approval and Issuance of U.S. Conditioning Patent
February 01, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Submission of Complete Response to Clinical Hold
January 15, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Expanded to Treatment of Cancer
November 27, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing Completed
November 15, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed
January 07, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375
November 28, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
September 18, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDA
September 14, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Patent Application Update
September 08, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
July 03, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-T
June 02, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option Grant
April 28, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T IND
July 10, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-T
May 09, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022
April 28, 2023
Via
ACCESSWIRE
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.